Livia Hecke Morais

Dr. Livia Hecke Morais

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2020 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
Livia Hecke MoraisLivia Hecke Morais
Livia Hecke Morais
HSHenry L. Schreiber
Henry L. Schreiber
SMSarkis K. Mazmanian
Sarkis K. Mazmanian

1 October 2020 in Current Biology
Verified
Journal Article
Open access
Livia Hecke MoraisLivia Hecke Morais
Livia Hecke Morais
AGAnna V. Golubeva
Anna V. Golubeva
GMGerard M. Moloney
Gerard M. Moloney
AMAngela Moya-Pérez
Angela Moya-Pérez
AVAna Paula Ventura-Silva
Ana Paula Ventura-Silva
JCJohn F Cryan
John F Cryan
Birth by Caesarean (C)-section impacts early gut microbiota colonization and is associated with an increased risk of developing immune and metabolic disorders. Moreover, alterations of the microbiome have been shown to affect neurodevelopmental trajectories. However, the long-term effects of C-section on neurobehavioral processes remain unknown. Here, we demonstrated that birth by C-section results in marked but transient changes in microbiome composition in the mouse, in particular, the abundance of Bifidobacterium spp. was depleted in early life. Mice born by C-section had enduring social, cognitive, and anxiety deficits in early life and adulthood. Interestingly, we found that these specific behavioral alterations induced by the mode of birth were also partially corrected by co-housing with vaginally born mice. Finally, we showed that supplementation from birth with a Bifidobacterium breve strain, or with a dietary prebiotic mixture that stimulates the growth of bifidobacteria, reverses selective behavioral alterations in C-section mice. Taken together, our data link the gut microbiota to behavioral alterations in C-section-born mice and suggest the possibility of developing adjunctive microbiota-targeted therapies that may help to avert long-term negative consequences on behavior associated with C-section birth mode.

8 November 2022 in eLife
Verified
Journal Article
Open access
RAReem Abdel-Haq
Reem Abdel-Haq
JSJohannes Cm Schlachetzki
Johannes Cm Schlachetzki
JBJoseph C Boktor
Joseph C Boktor
TCThaisa M Cantu-Jungles
Thaisa M Cantu-Jungles
TTTaren Thron
Taren Thron
SMSarkis K Mazmanian
Sarkis K Mazmanian
Parkinson’s disease (PD) is a movement disorder characterized by neuroinflammation, α-synuclein pathology, and neurodegeneration. Most cases of PD are non-hereditary, suggesting a strong role for environmental factors, and it has been speculated that disease may originate in peripheral tissues such as the gastrointestinal (GI) tract before affecting the brain. The gut microbiome is altered in PD and may impact motor and GI symptoms as indicated by animal studies, although mechanisms of gut-brain interactions remain incompletely defined. Intestinal bacteria ferment dietary fibers into short-chain fatty acids, with fecal levels of these molecules differing between PD and healthy controls and in mouse models. Among other effects, dietary microbial metabolites can modulate activation of microglia, brain-resident immune cells implicated in PD. We therefore investigated whether a fiber-rich diet influences microglial function in α-synuclein overexpressing (ASO) mice, a preclinical model with PD-like symptoms and pathology. Feeding a prebiotic high-fiber diet attenuates motor deficits and reduces α-synuclein aggregation in the substantia nigra of mice. Concomitantly, the gut microbiome of ASO mice adopts a profile correlated with health upon prebiotic treatment, which also reduces microglial activation. Single-cell RNA-seq analysis of microglia from the substantia nigra and striatum uncovers increased pro-inflammatory signaling and reduced homeostatic responses in ASO mice compared to wild-type counterparts on standard diets. However, prebiotic feeding reverses pathogenic microglial states in ASO mice and promotes expansion of protective disease-associated macrophage (DAM) subsets of microglia. Notably, depletion of microglia using a CSF1R inhibitor eliminates the beneficial effects of prebiotics by restoring motor deficits to ASO mice despite feeding a prebiotic diet. These studies uncover a novel microglia-dependent interaction between diet and motor symptoms in mice, findings that may have implications for neuroinflammation and PD.

1 April 2018 in Behavioural Pharmacology
Verified
Journal Article
Closed access
Livia Hecke MoraisLivia Hecke Morais
Livia Hecke Morais
DHDaniela B. Hara
Daniela B. Hara
MBMaíra A. Bicca
Maíra A. Bicca
APAnicleto Poli
Anicleto Poli
RTReinaldo N. Takahashi
Reinaldo N. Takahashi
The factors that trigger the pathophysiology of Parkinson’s disease (PD) are unknown. However, it is suggested that environmental factors, such as exposure to pesticides, play an important role, in addition to genetic predisposition and aging. Early signs of PD can appear in the gastrointestinal (GI) tract and in the olfactory system, preceding the onset of motor impairments by many years. The present study assessed the effects of oral rotenone administration (30 mg/kg) in inducing GI and olfactory dysfunctions associated with PD in mice. Here we show that rotenone transiently increased myeloperoxidase activity within 24 h of administration. Leucocyte infiltration in the colon, associated with histological damage and disrupted GI motility, were observed following treatment with rotenone for 7 days. Moreover, 7 days of treatment with rotenone disrupted olfactory discrimination in mice without affecting social recognition ability. The presence of specific deficits in olfactory function occurred with a concomitant decrease in tyrosine hydroxylase-positive neurons and an increase in serotonin (5-hydroxytryptamine) turnover in the olfactory bulb. These findings suggest that in Swiss mice, exposure to rotenone induces GI and olfactory dysfunction involving immunological and neurotransmitter alterations, similar to early signs of PD. This provides further evidence for the involvement of the gut–brain axis in PD.

1 September 2012 in Pharmacological Reports
Verified
Journal Article
Closed access
Livia Hecke MoraisLivia Hecke Morais
Livia Hecke Morais
MLMarcelo M.S. Lima
Marcelo M.S. Lima
Bruno Jacson MartynhakBruno Jacson Martynhak
Bruno Jacson Martynhak
RSRonise Santiago
Ronise Santiago
TTTatiane T. Takahashi
Tatiane T. Takahashi
MVMaria A.B.F. Vital
Maria A.B.F. Vital

1 April 2018 in Behavioural Pharmacology
Verified
Journal Article
Closed access
Livia Hecke MoraisLivia Hecke Morais
Livia Hecke Morais
DFDaniela Felice
Daniela Felice
AGAnna V. Golubeva
Anna V. Golubeva
GMGerard M. Moloney
Gerard M. Moloney
TDTimothy G. Dinan
Timothy G. Dinan
JCJohn F Cryan
John F Cryan
There is a growing realization that the severity of the core symptoms of autism spectrum disorders and schizophrenia is associated with gastrointestinal dysfunction. Nonetheless, the mechanisms underlying such comorbidities remain unknown. Several genetic and environmental factors have been linked to a higher susceptibility to neurodevelopmental abnormalities. The maternal immune activation (MIA) rodent model is a valuable tool for elucidating the basis of this interaction. We induced MIA with polyinosinic–polycytidylic acid (poly I:C) at gestational day 12.5 and assessed behavioural, physiological and molecular aspects relevant to the gut–brain axis in the offspring of an outbred (NIH Swiss) and an inbred (C57BL6/J) mouse strain. Our results showed that the specific MIA protocol employed induces social deficits in both strains. However, alterations in anxiety and depression-like behaviours were more pronounced in NIH Swiss mice. These strain-specific behavioural effects in the NIH Swiss mice were associated with marked changes in important components of gut–brain axis communication: the endocrine response to stress and gut permeability. In addition, MIA-induced changes in vasopressin receptor 1a mRNA expression in the hypothalamus were observed in NIH Swiss mice only. Taken together, these data suggest that genetic background is a critical factor in susceptibility to the gut–brain axis effects induced by MIA.